Biliary Stricture
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Boston ScientificCA - Valencia
3 programs1
WallFlex Biliary RX Fully Covered Stent SystemPhase 31 trial
ERCPN/A1 trial
WallFlex™ Biliary RX Fully Covered Stent System RMVN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Boston ScientificWallFlex Biliary RX Fully Covered Stent System
Boston ScientificERCP
Boston ScientificWallFlex™ Biliary RX Fully Covered Stent System RMV
Clinical Trials (3)
Total enrollment: 885 patients across 3 trials
WallFlex Biliary Fully Covered (FC) Benign Stricture Study
Start: Dec 2009Est. completion: Nov 2017187 patients
Phase 3Completed
SpyGlass AMEA Registry
Start: Nov 2014Est. completion: Oct 2016526 patients
N/ACompleted
WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study
Start: Sep 2012Est. completion: Sep 2020172 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.